Article
A Multi-Biomarker Prediction Model Integrating Genetics, Hematological Indices, and Fibrosis Stage to Forecast Non-Response in HCV Genotype 4
2025-09-24
Abstract excerpt
<h4>Introduction: </h4> The Hepatitis C virus (HCV) genotype 4 is very widespread in Egypt, leading to considerable rates of cirrhosis, hepatocellular cancer, and death. Notwithstanding the efficacy of direct-acting antivirals (DAAs) in attaining cure rates over 90%, instances of treatment failure persist. Identifying predictors of non-response is essential for optimizing first-line therapy and advancing eliminati...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ee503071-329d-53e4-a1a5-610c10f287b8
- DOI
- 10.22541/au.175868487.76800218/v1
